Biolidics: Placements-PROPOSED SUBSCRIPTION OF 98,500,000 NEW ORDINARY SHARES IN THE ISSUED SHARE CAPITAL OF THE COMPANY
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.